Eli Lilly to buy genetic medicine developer Akouos for $487 million Reuters Nawigacja wpisu GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D – GSK RHR: A Functional Medicine Approach to Parkinson’s Disease – Chris Kresser